Abstract
To test the hypothesis that uterine decidua may modulate trophoblast function, trophoblasts and decidual cells were isolated from term placentas by enzymatic digestion and Percoll gradient centrifugation. Placental trophoblasts were cocultured with decidual cells and trophoblasts or JEG-3 choriocarcinoma cells were incubated with medium conditioned by decidual cells (DCM) for 72-96 h. In cocultures decidual cells inhibited choriogonadotropin (hCG) release from trophoblasts by 75% in comparison with controls (P < 0.001). The DCM contained a factor that markedly inhibited hCG release from trophoblasts and JEG cells in vitro compared with controls. The inhibitory effect of the factor on hCG release was dose dependent, and could be eliminated by boiling the DCM for 30 min or proteolytic enzyme treatment. Ultrafiltration and Sephadex G-50 fractionation of the DCM indicated that the apparent molecular mass was 7,000-10,000 D. DCM also inhibited the stimulatory effect of exogenous cAMP on hCG secretion by JEG-3 cells, suggesting that DCM may interfere with activation of the cAMP-dependent protein kinases or transcription of hCG genes. These results suggest that the release of trophoblast hCG is under local paracrine control, regulated in part by a protein released by decidual cells.
Introduction
During pregnancy, the relationship between the placenta (fetal tissue) and the decidua (maternal tissue) is a complex, bidirectional exchange. While it was well-established that the placenta releases factors that influence maternal physiology—such as stimulating the production of decidual prolactin—the reverse relationship was less understood.
This study sought to determine if the maternal decidua plays an active role in modulating placental function. Specifically, researchers investigated whether the decidua produces a substance that regulates the release of human chorionic gonadotropin (hCG), the "pregnancy hormone" essential for maintaining the early stages of gestation.
Methods
The study utilized primary cell cultures and biochemical characterization. Trophoblasts and decidual cells were isolated from human term placentas (n=10) using enzymatic digestion followed by Percoll gradient centrifugation. Experimental models included cocultures of maternal and fetal cells and the use of Decidua Conditioned Medium (DCM)—the nutrient broth containing factors secreted by decidual cells. The JEG-3 choriocarcinoma cell line was also used as a standardized model for trophoblast behavior. To characterize the inhibitory factor, DCM was subjected to heat stability tests (boiling), proteolytic enzyme treatment, and size-exclusion chromatography (Sephadex G-50). Hormone levels (hCG, hPL, and prolactin) were quantified via radioimmunoassays.
Key Results
The study demonstrated that the decidua is an active local endocrine organ that regulates placental output. In cocultures, decidual cells reduced hCG release from trophoblasts by 75% compared to controls ($P < 0.001$). This inhibitory effect was dose-dependent and attributed to a heat-labile protein with an apparent molecular mass between 7,000 and 10,000 Daltons.
Interestingly, the regulation was differential: while the decidual factor inhibited hCG, it significantly stimulated the release of human placental lactogen (hPL) from primary trophoblasts by approximately 2.5-fold. This suggests a nuanced balancing act where the decidua tunes different placental functions simultaneously.
Discussion and Mechanism
The discovery of this 7,000–10,000 Dalton protein identifies a new paracrine regulator of placental function. Crucially, this factor is distinct from prolactin (22,500 Daltons), which was previously considered a candidate for this role.
Mechanistically, the factor appears to interfere with the cAMP-dependent signaling pathway. Because DCM inhibited the stimulatory effects of exogenous cAMP on hCG secretion, the authors suggest the protein works either by blocking protein kinases or by interfering with the transcription of hCG genes. This indicates that the maternal-fetal interface involves a sophisticated local "dialogue" to manage hormone levels throughout pregnancy.
Limitations and Future Work
While the study characterizes the protein's size and nature, the specific identity and gene sequence of this "decidual inhibitory factor" remain to be determined. Furthermore, as the study was conducted in vitro using term placental tissues, future research is needed to validate these findings in vivo and to explore the activity of this inhibitor during the first trimester, when hCG levels naturally peak and then decline.
Summary updated